pancreatic adenocarcinoma
Showing 26 - 50 of 6,047
Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)
Recruiting
- Pancreatic Adenocarcinoma
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jul 15, 2022
Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)
Recruiting
- Pancreatic Adenocarcinoma
- mFOLFIRINOX
- Gemcitabine / Nab-paclitaxel
-
Hamilton, Ontario, CanadaJuravinski Hospital
Aug 5, 2022
Pancreatic Cancer Trial in Shanghai (Adebrelimab, mRNA tumor vaccines)
Not yet recruiting
- Pancreatic Cancer
- Adebrelimab
- mRNA tumor vaccines
-
Shanghai, Shanghai, ChinaDepartment of Pancreatic Surgery, Fudan University Shanghai Canc
Dec 4, 2023
Fluorodeoxyglucose F18 Trial in Ghent (Positron Emissie Tomografie - Computer Tomografie)
Recruiting
- Fluorodeoxyglucose F18
- Positron Emissie Tomografie - Computer Tomografie
-
Ghent, East-flanders, BelgiumUniversity Hospital Ghent
Jan 16, 2023
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
Pancreatic Adenocarcinoma Trial in Dallas (drug, procedure, other)
Completed
- Pancreatic Adenocarcinoma
- 3'-deoxy-3'-[F-18] fluorothymidine: [F-18]FLT
- +3 more
-
Dallas, TexasUT Southwestern Medical Center
Oct 10, 2022
The HELPP Score: A Pretreatment Score to Predict Survival in
Not yet recruiting
- Pancreatic Adenocarcinoma
-
Vienna, AustriaDepartment of General Surgery, Division of Visceral Surgery, Med
Feb 21, 2023
Survival, Quality of Life and Resectability in Locally Advanced
Recruiting
- Pancreas Cancer
- +8 more
-
Umeå, SwedenSurgical Clinic at Umeå University Hospital
Nov 23, 2022
Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)
Active, not recruiting
- Pancreatic Adenocarcinoma
- 9-ING-41
- +3 more
-
Fairway, KansasKansas University Cancer center
Nov 2, 2022
Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in Houston (Autologous DC vaccine)
Recruiting
- Pancreatic Adenocarcinoma
- Pancreatic Cancer
- Autologous DC vaccine
-
Houston, Texas
- +2 more
Aug 17, 2022
Surgery After Neoadjuvant Chemotherapy in Locally Advanced
Completed
- Postoperative Complications
- surgery after neoadjuvant chemotherapy
-
Seoul, Korea, Republic ofAsan medical center
Jun 1, 2023
Pancreatic Ductal Adenocarcinoma Trial in Cleveland (Ivosidenib, mFOLFIRINOX)
Recruiting
- Pancreatic Ductal Adenocarcinoma
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Aug 15, 2022
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer, Pancreas Cancer Trial in Quebec city (Cholesterol metabolism disruption)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- +3 more
- Cholesterol metabolism disruption
-
Quebec city, Quebec, CanadaCHU de Québec-Université Laval
Oct 17, 2022
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in
Not yet recruiting
- Pancreatic Adenocarcinoma Metastatic
-
Pessac, FranceCHU Bordeaux
Aug 17, 2023
Metastatic Pancreatic Adenocarcinoma Trial in Shanghai (Ascorbate, Nab paclitaxel, Gemcitabine)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Ascorbate
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Cancer Center
Aug 29, 2023
Locally Advanced Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer American Joint Committee on Cancer v8, Unresectable
Not yet recruiting
- Locally Advanced Pancreatic Adenocarcinoma
- +2 more
- Biospecimen Collection
- +8 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Nov 9, 2023
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Ann Arbor (Devimistat, Modified FOLFIRINOX)
Not yet recruiting
- Metastatic Pancreatic Adenocarcinoma
- Devimistat
- Modified FOLFIRINOX
-
Ann Arbor, MichiganRogel Cancer Center
Jun 26, 2023
Resected Pancreatic Adenocarcinoma
Completed
- Pancreatic Cancer Resectable
- Multigene panel for next-generation sequencing
-
Shanghai, Shanghai, ChinaRuijin Hospital
Jul 31, 2022
Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago
Terminated
- Pancreatic Adenocarcinoma
- +2 more
- Pembrolizumab
- Wild-type Reovirus
-
Chicago, IllinoisNorthwestern University
Sep 6, 2022
EHR-based Pancreatic Cancer Risk Model
Active, not recruiting
- Pancreatic Adenocarcinoma
- Predictive Cancer Model
- Pancreatic Cancer Risk Model (PRISM)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Aug 1, 2023
Pancreas Cancer, Pancreatic Adenocarcinoma Trial in Verona (Systematic lymphadenectomy)
Recruiting
- Pancreas Cancer
- Pancreatic Adenocarcinoma
- Systematic lymphadenectomy
-
Verona, VR, ItalyUnit of Pancreatic Surgery - G.B. Rossi Hospital, University of
Nov 15, 2023